Sawai Group Holdings Co., Ltd.
Research Sawai Group Holdings Co., Ltd. (4887.T) on Bullrun: market cap JPY 192.28B, P/E 20.3, dividend yield 3.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4887.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 192.28B
- P/E20.3
- Dividend yield3.4%
- Financial periodFY2026
- RevenueJPY 201.68B
- Revenue growth6.7%
- Net incomeJPY 10.44B
- Free cash flow-JPY 17.04B
- Gross margin29.2%
Valuation Snapshot
latest market cap is JPY 192.28B; P/E is 20.3; dividend yield is 3.4%.
Peer valuation comparison
Latest P/E is 20.33x versus a Healthcare sector median of 21.69x (6.3% below).
Latest dividend yield is 3.35% versus a Healthcare sector median of 2.41% (39.0% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 201.68B | JPY 10.44B | -JPY 17.04B | 29.2% | 90.1 | JPY 28.99B | JPY 105.02B | JPY 178.56B |
| FY2025 | JPY 189.02B | JPY 11.97B | JPY 337.00M | 29.8% | 184.45 | JPY 38.79B | JPY 91.34B | JPY 173.85B |
| FY2024 | JPY 176.86B | JPY 13.70B | -JPY 1.50B | 30.7% | 103.93 | JPY 26.37B | JPY 82.89B | JPY 212.66B |
| FY2023 | JPY 163.70B | JPY 12.67B | -JPY 14.12B | 30.7% | 96.2 | JPY 33.08B | JPY 73.13B | JPY 201.64B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 192.28B | 20.3 | 3.4% | 56 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 56 JPY, yield 3.4%.
| Year | Dividends/share |
|---|---|
| FY2026 | 56 JPY |
| FY2025 | 54 JPY |
| FY2024 | 47.67 JPY |
| FY2023 | 43.33 JPY |
About Sawai Group Holdings Co., Ltd.
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the manufacture and sale of pharmaceuticals. The company offers generic drugs in various dosage forms for therapeutic areas comprising cardiovascular and antibiotic preparations, central nervous system drugs, other metabolic drugs, digestive tract medicines, blood and body fluid medications, allergy medications, respiratory medicine, vitamin supplements, oncology drugs, chemotherapeutic agents, genitourinary and anal drugs, and others.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sawai Group Holdings Co., Ltd.'s market cap?
Sawai Group Holdings Co., Ltd.'s market capitalization is JPY 192.28B.
What is Sawai Group Holdings Co., Ltd.'s P/E ratio?
Sawai Group Holdings Co., Ltd.'s price-to-earnings (P/E) ratio is 20.3.
Does Sawai Group Holdings Co., Ltd. pay a dividend?
Sawai Group Holdings Co., Ltd. has a dividend yield of 3.4%.
What does Sawai Group Holdings Co., Ltd. do?
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the manufacture and sale of pharmaceuticals. The company offers generic drugs in various dosage forms for therapeutic areas comprising cardiovascular and antibiotic preparations, central nervous system drugs, other metabolic drugs, digestive tract medicines, blood and body fluid medications, allergy medications, respiratory medicine, vitamin supplements, oncology drugs, chemotherapeutic agents, genitourinary and anal drugs, and others. It sells its generic drugs through distributors, wholesalers, and retailers.